Search

Search Results
Results 2301 - 2310 of 8427 for Skin Cancer
  • News - 26 Apr 2025
    Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, have existed in the human body as a seeming paradox, causing inflammation...
  • Drug - 24 Feb 2025
    Consumer Medicine Information (CMI) about Gardasil 9 intended for persons living in Australia.
  • Drug - 21 Feb 2025
    Consumer Medicine Information (CMI) about Methoblastin intended for persons living in Australia.
  • Drug - 21 Feb 2025
    Consumer Medicine Information (CMI) about Methoblastin Blister intended for persons living in Australia.
  • Drug - 14 Feb 2025
    Consumer Medicine Information (CMI) about Premarin (Conjugated estrogens Tablets) intended for persons living in Australia.
  • Health - 13 Feb 2025
    This article details the punch biopsy procedure, a key diagnostic tool for dermatologists to assess suspicious skin lesions and inflammatory conditions.
  • News - 3 Feb 2025
    Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could be considered a therapeutic approach only in stage 0 of progression (in...
  • News - 21 Jan 2025
    A new online guide has launched to support and empower people with vulval lichen sclerosus (LS) to learn about the condition, access the right treatment and live more comfortably.
  • News - 16 Jan 2025
    A study links PFAS contamination in drinking water to increased cancer risks, highlighting significant impacts on digestive, endocrine, and respiratory systems.
  • Drug - 24 Nov 2024
    Consumer Medicine Information (CMI) about DBL Dacarbazine intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.